Glutathione‐related enzymes in brain in Parkinson's disease

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Annals of Neurology

• Publication date

  1994-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/ana.410360306PMID 8080243
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

  1994cited by this paper
• Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study

  1994cited by this paper
• Effects of 1‐Methyl‐4‐Phenylpyridinium on Isolated Rat Brain Mitochondria: Evidence for a Primary Involvement of Energy Depletion

  1994cited by this paper
• Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease

  1994cited by this paper
• Glutathione peroxidase, glial cells and Parkinson's disease.

  1993cited by this paper
• Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental lewy body disease

  1992cited by this paper
• Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease.

  1992cited by this paper
• Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease.

  1992cited by this paper
• The physiological consequences of glutathione variations.

  1992cited by this paper
• Mitochondrial poisons cause depletion of reduced glutathione in isolated hepatocytes.

  1992cited by this paper
• II. Localization of Pi class glutathione‐S‐transferase in the forebrains of neonatal and young rats: Evidence for separation of astrocytic and oligodendrocytic lineages

  1992cited by this paper
• The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it

  1992cited by this paper
• Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.

  1991cited by this paper
• Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway.

  1991cited by this paper
• Ageing and Parkinson's disease: substantia nigra regional selectivity.

  1991cited by this paper
• Cellular and regional distribution of reduced glutathione in the nervous system of the rat: histochemical localization by mercury orange and o-phthaldialdehyde-induced histofluorescence.

  1991cited by this paper
• Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy.

  1991cited by this paper
• Mitochondrial Complex I Deficiency in Parkinson's Disease

  1989cited by this paper
• Mitochondrial complex I deficiency in Parkinson's disease.

  1989cited by this paper
• Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

  1989cited by this paper
• Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

  1989cited by this paper
• Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

  1989cited by this paper
• A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra

  1989cited by this paper
• Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease

  1989cited by this paper
• Deprenyl suppresses the oxidant stress associated with increased dopamine turnover

  1989cited by this paper
• The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

  1988cited by this paper
• Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus.

  1988cited by this paper
• Characterization and Localization of Glutathione‐S‐Transferases in Rat Brain and Binding of Hormones, Neurotransmitters, and Drugs

  1988cited by this paper
• IV. MPTP, MPP+ and mitochondrial function

  1987cited by this paper
• MPTP, MPP+ and mitochondrial function.

  1987cited by this paper
• In vitro characterisation of dopamine receptors in the superior colliculus of the rat.

  1987cited by this paper
• Histochemical evaluation of glutathione in brain.

  1987cited by this paper
• 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) cause rapid ATP depletion in isolated hepatocytes.

  1986cited by this paper
• Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients.

  1986cited by this paper
• Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP.

  1986cited by this paper
• Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

  1985cited by this paper
• Glutathione peroxidase activity in Parkinson's disease brain.

  1985cited by this paper
• Origin and turnover of mitochondrial glutathione.

  1985cited by this paper
• 16 – Oxidative Stress in the Nervous System

  1985cited by this paper
• Selective modification of glutathione metabolism.

  1983cited by this paper
• Medicine and the Law

  1983cited by this paper
• Parkinson's disease: A disorder due to nigral glutathione deficiency?

  1982cited by this paper
• A simple procedure for electron microscopy of Golgi-impregnated nerve cells.

  1982cited by this paper
• Brain peroxidase and catalase in Parkinson disease.

  1975cited by this paper
• CONCENTRIC HYALIN INTRANEURONAL INCLUSIONS OF LEWY TYPE IN THE BRAINS OF ELDERLY PERSONS (50 INCIDENTAL CASES): RELATIONSHIP TO PARKINSONISM

  1969cited by this paper

• Multi-omics study identifies diagnostic metabolic signatures of early Parkinson's disease associated with dysregulated glutathione and TCA cycle metabolism.

  2026cites this paper
• park+/+ and park−/− Drosophila have sexually dimorphic brain redox chemistry

  2025cites this paper
• Metabolomics in Parkinson’s Disease and Correlation with Disease State

  2025cites this paper
• Dimethyl Fumarate Reduces Methylglyoxal-derived Carbonyl Stress Through Nrf2/GSH Activation in SH-SY5Y Cells

  2024cites this paper
• Natural variation in age-related dopamine neuron degeneration is glutathione dependent and linked to life span

  2024cites this paper
• The vicious circle between homocysteine, methyl group-donating vitamins and chronic levodopa intake in Parkinson’s disease

  2023cites this paper
• Abscisic acid ameliorates motor disabilities in 6-OHDA-induced mice model of Parkinson's disease

  2023cites this paper
• Melanin—The Éminence Grise of Melanoma and Parkinson’s Disease Development

  2023cites this paper
• Neuronal glutathione loss leads to neurodegeneration involving gasdermin activation

  2023cites this paper
• LRRK2 Attenuates Antioxidant Response in Familial Parkinson’s Disease Derived Neural Stem Cells

  2023cites this paper
• Transsulfuration pathway: a targeting neuromodulator in Parkinson’s disease

  2023cites this paper
• Pesticides Exposure-Induced Changes in Brain Metabolome: Implications in the Pathogenesis of Neurodegenerative Disorders

  2022cites this paper
• Glutathione S-Transferase Regulates Mitochondrial Populations in Glutathione S-Transferase Regulates Mitochondrial Populations in Axons through Increased Glutathione Oxidation Axons through Increased Glutathione Oxidation

  2022cites this paper
• POTENTIAL PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISORDERS BY OLIVE POLYPHENOLS AND HYDROX.

  2022cites this paper
• The Critical Role of Glutamine Transporter ASCT2 in Parkinson’s Disease Progression

  2022cites this paper
• Cellular and Molecular Events Leading to Paraquat-Induced Apoptosis: Mechanistic Insights into Parkinson’s Disease Pathophysiology

  2022cites this paper
• 4,4'-Dimethoxychalcone regulates redox homeostasis by targeting riboflavin metabolism in Parkinson's disease therapy.

  2021cites this paper
• Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies

  2021cites this paper
• Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson’s disease

  2021cites this paper
• The Role of NCOA4-Mediated Ferritinophagy in Ferroptosis.

  2021cites this paper
• NRF2 Activation and Downstream Effects: Focus on Parkinson’s Disease and Brain Angiotensin

  2021cites this paper
• Glutathione: Role in Oxidative/Nitrosative Stress, Antioxidant Defense, and Treatments

  2021cites this paper
• Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease

  2021cites this paper
• Ferroptosis-Related Genes in Neurodevelopment and Central Nervous System

  2021cites this paper
• Flavonoids targeting NRF2 in neurodegenerative disorders.

  2020cites this paper
• The glutathione system in Parkinson's disease and its progression.

  2020cites this paper
• Disorders of glutathione metabolism

  2020cites this paper
• The roles of iron and HFE genotype in neurological diseases.

  2020cites this paper
• Neurodegenerative Diseases: Potential Effect of Glutathione

  2020cites this paper
• Trichloroethylene, a ubiquitous environmental contaminant in the risk for Parkinson's disease.

  2020cites this paper
• Mitochondrial Glutathione: Recent Insights and Role in Disease

  2020cites this paper
• γ-Glutamyltranspeptidase from Bacillus amyloliquefaciens: transpeptidation activity enhancement and L-theanine production.

  2020cites this paper
• Protective effect of co-administration of vitamins C and E on reserpine-induced oxidative stress in mice

  2019cites this paper
• Glutathione S-Transferase Regulates Mitochondrial Populations in Axons through Increased Glutathione Oxidation

  2019cites this paper
• The bimodal mechanism of interaction between dopamine and mitochondria as reflected in Parkinson’s disease and in schizophrenia

  2019cites this paper
• 5-S-cysteinyl-dopamine a neurotoxic endogenous metabolite of dopamine: Implications for Parkinson's disease.

  2019cites this paper
• Chloramphenicol Mitigates Oxidative Stress by Inhibiting Translation of Mitochondrial Complex I in Dopaminergic Neurons of Toxin-Induced Parkinson's Disease Model

  2019cites this paper
• The Physiopathological Crossroads of Aging

  2019cites this paper
• The mercapturic acid pathway

  2019cites this paper
• Glutathione-selective “off–on” fluorescence response by a probe-displaced modified ligand for its detection in biological domains

  2019cites this paper
• Geraniol Protects Against the Protein and Oxidative Stress Induced by Rotenone in an In Vitro Model of Parkinson’s Disease

  2018cites this paper
• Chapter 1 Introductory Chapter : A General Overview of Glutathione , Glutathione Transport , and Glutathione Applications

  2018cites this paper
• Metabolomic investigations in cerebrospinal fluid of Parkinson's disease

  2018cites this paper
• Repeated‐Dose Oral N‐Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress

  2018cites this paper
• Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?

  2017cites this paper
• Humulus japonicus Prevents Dopaminergic Neuron Death in 6-Hydroxydopamine-Induced Models of Parkinson's Disease

  2017cites this paper
• Immunotherapies for Movement Disorders: Parkinson’s Disease and Amyotrophic Lateral Sclerosis

  2017cites this paper
• Gclc deficiency in mouse CNS causes mitochondrial damage and neurodegeneration

  2017cites this paper
• Redox Signaling Mediated by Thioredoxin and Glutathione Systems in the Central Nervous System

  2017cites this paper
• Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?

  2017cites this paper
• Nexus between mitochondrial function, iron, copper and glutathione in Parkinson's disease

  2017cites this paper
• Trichloroethylene exposure aggravates behavioral abnormalities in mice that are deficient in superoxide dismutase.

  2016cites this paper
• Sustained Effects of Neonatal Systemic Lipopolysaccharide on IL-1β and Nrf2 in Adult Rat Substantia Nigra Are Partly Normalized by a Spirulina-Enriched Diet

  2016cites this paper
• Effects of crocin on brain oxidative damage and aversive memory in a 6-OHDA model of Parkinson’s disease

  2016cites this paper
• S‐Glutathionylation of Keap1: a new role for glutathione S‐transferase pi in neuronal protection

  2016cites this paper
• Brain effects of manganese exposure in mice pups during prenatal and breastfeeding periods.

  2016cites this paper
• Astrocytes Surviving Severe Stress Can Still Protect Neighboring Neurons from Proteotoxic Injury

  2016cites this paper
• Phosphonate-based irreversible inhibitors of human γ-glutamyl transpeptidase (GGT). GGsTop is a non-toxic and highly selective inhibitor with critical electrostatic interaction with an active-site residue Lys562 for enhanced inhibitory activity.

  2016cites this paper
• Oxidative Modification and Its Implications for the Neurodegeneration of Parkinson’s Disease

  2016cites this paper
• Melatonin prevents the dynamin‐related protein 1‐dependent mitochondrial fission and oxidative insult in the cortical neurons after 1‐methyl‐4‐phenylpyridinium treatment

  2016cites this paper
• Hypochlorite converts cysteinyl-dopamine into a cytotoxic product: A possible factor in Parkinson's Disease.

  2016cites this paper
• Ion-catalyzed reactive oxygen species in sporadic models of parkinson’s disease

  2016cites this paper
• Impairment of Mitochondria-Associated Processes in Parkinson's Disease

  2016cites this paper
• Insulin-like growth factor 1 specifically up-regulates expression of modifier subunit of glutamate-cysteine ligase and enhances glutathione synthesis in SH-SY5Y cells.

  2016cites this paper
• Influence of different neuroprotective drugs on dopamine neurotoxicity induced by 3,4-methylenedioxymethamphetamine and MPTP in mice

  2016cites this paper
• Parkinson's Disease: The Mitochondria-Iron Link

  2016cites this paper
• Topographical differences in stress vulnerability in experimental Parkinson's disease

  2015cites this paper
• Treadmill exercise activates Nrf2 antioxidant system to protect the nigrostriatal dopaminergic neurons from MPP+ toxicity.

  2015cites this paper
• Modulation of Microglial Activity by GDNF

  2015cites this paper
• Application of Glutathione as Anti-Oxidative and Anti-Aging Drugs.

  2015cites this paper
• Chronic Brain Inflammation: The Neurochemical Basis for Drugs to Reduce Inflammation

  2015cites this paper
• Assessment of Protective Role of Multifunctional Dopamine Agonist D-512 Against Oxidative Stress Produced by Depletion of Glutathione in PC12 Cells: Implication in Neuroprotective Therapy for Parkinson’s Disease

  2015cites this paper
• Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation.

  2015cites this paper
• Enhanced Neuroprotective Effects of Coadministration of Tetrandrine with Glutathione in Preclinical Model of Parkinson's Disease

  2015cites this paper
• Effect of pH on the Hydrolytic Kinetics of Gamma-Glutamyl Transferase from Bacillus subtilis

  2014cites this paper
• Roles of Glutathione in Antioxidant Defense, Inflammation, and Neuron Differentiation in the Thalamus of HIV-1 Transgenic Rats

  2014cites this paper
• Glutathione-analogous peptidyl phosphorus esters as mechanism-based inhibitors of γ-glutamyl transpeptidase for probing cysteinyl-glycine binding site.

  2014cites this paper
• Progressive Parkinsonism by acute dysfunction of excitatory amino acid transporters in the rat substantia nigra.

  2014cites this paper
• Complex Deregulation and Expression of Cytokines and Mediators of the Immune Response in Parkinson's Disease Brain is Region Dependent

  2014cites this paper
• Gamma-glutamyl transferases: A structural, mechanistic and physiological perspective

  2014cites this paper
• Dynamics of the glutathione/glutaredoxin system.

  2014cites this paper
• 5‐S‐cysteinyldopamine neurotoxicity: Influence on the expression of α‐synuclein and ERp57 in cellular and animal models of Parkinson's disease

  2014cites this paper
• Antioxidant potential of melatonin enhances the response to L-dopa in 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine-parkinsonian mice

  2013cites this paper
• Differential microglial activation in neurodegenerative diseases

  2013cites this paper
• Progress Towards Understanding Of Mechanisms Of Action Of Potent Multifunctional Disease Modifying Therapeutics For Parkinson's Disease & Investigating The Methamphetamine-Induced Striatal Microglia Activation.

  2013cites this paper
• Deferoxamine blocks death induced by glutathione depletion in PC 12 cells.

  2013cites this paper
• The conjugation of microcystin-RR by human recombinant GSTs and hepatic cytosol.

  2013cites this paper
• Glutathione metabolism and Parkinson's disease.

  2013cites this paper
• Molecular Events Underlying Parkinson’s Disease – An Interwoven Tapestry

  2013cites this paper
• Novel Insights into Eukaryotic γ-Glutamyltranspeptidase 1 from the Crystal Structure of the Glutamate-bound Human Enzyme*

  2013cites this paper
• Genetic Insights into Sporadic Parkinson's Disease Pathogenesis

  2013cites this paper
• Epalrestat increases intracellular glutathione levels in Schwann cells through transcription regulation

  2013cites this paper
• Lipophilic adamantyl- or deferasirox-based conjugates of desferrioxamine B have enhanced neuroprotective capacity: implications for Parkinson disease.

  2013cites this paper
• The Role of skn-1 in Methylmercury-Induced Latent Dopaminergic Neurodegeneration

  2013cites this paper
• Exploring the unfolding mechanism of γ-glutamyltranspeptidases: the case of the thermophilic enzyme from Geobacillus thermodenitrificans.

  2012cites this paper
• Charcot-Marie-Tooth disease CMT4A: GDAP1 increases cellular glutathione and the mitochondrial membrane potential.

  2012cites this paper
• Acetyl-L-carnitine and α-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy.

  2012cites this paper
• Two Faces of 1,2,3,4-Tetrahydroisoquinoline Mode of Action in the Mammalian Brain: Is It an Endogenous Neurotoxin or a Neuromodulator?

  2012cites this paper
• Interplay between Alpha-Synuclein and Oxidative Stress in Parkinson´s Disease Cell Models

  2012cites this paper
• Long term exposure to cypermethrin induces nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood.

  2012cites this paper